$50,000 of DENTSPLY SIRONA lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to dental services; Issues related to competitive bidding proposed changes. Issues related to dental services under Medicare Advantage; Issues related to competitive bidding proposed changes. Issues related to international trade and tariff policy regarding dental supplies with the European Union, Canada, & Mexico."
You can find more data on corporate lobbying on Quiver Quantitative.
XRAY Insider Trading Activity
XRAY insiders have traded $XRAY stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- GREGORY T LUCIER sold 82,200 shares for an estimated $915,708
- LESLIE F VARON purchased 9,337 shares for an estimated $99,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
XRAY Hedge Fund Activity
We have seen 238 institutional investors add shares of XRAY stock to their portfolio, and 204 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 10,749,500 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $136,411,155
- NUANCE INVESTMENTS, LLC removed 8,987,359 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $142,719,260
- ARMISTICE CAPITAL, LLC added 5,234,587 shares (+1044.0%) to their portfolio in Q3 2025, for an estimated $66,426,909
- JACOBS LEVY EQUITY MANAGEMENT, INC added 4,003,606 shares (+662.0%) to their portfolio in Q3 2025, for an estimated $50,805,760
- D. E. SHAW & CO., INC. added 1,669,643 shares (+136.1%) to their portfolio in Q3 2025, for an estimated $21,187,769
- BRICKWOOD ASSET MANAGEMENT LLP added 1,496,935 shares (+5515.8%) to their portfolio in Q3 2025, for an estimated $18,996,105
- INVENOMIC CAPITAL MANAGEMENT LP added 1,425,637 shares (+48.7%) to their portfolio in Q3 2025, for an estimated $18,091,333
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
XRAY Analyst Ratings
Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 12/16/2025
- UBS issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for XRAY, check out Quiver Quantitative's $XRAY forecast page.
XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 8 analysts offer price targets for $XRAY in the last 6 months, with a median target of $12.5.
Here are some recent targets:
- Michael Petusky from Barrington Research set a target price of $14.0 on 12/16/2025
- Jeffrey Johnson from Baird set a target price of $12.0 on 12/16/2025
- Glen Santangelo from Barclays set a target price of $12.0 on 12/09/2025
- Lilia-Celine Lozada from JP Morgan set a target price of $12.0 on 11/07/2025
- Vik Chopra from Wells Fargo set a target price of $12.0 on 11/07/2025
- Kevin Caliendo from UBS set a target price of $23.0 on 10/28/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $13.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
